Ryan White Care Hepatitis C & B Language
NATAP Webinars
The Race to 2030 HCV Elimination Progress
Friday, February 7th, 2025 - 12:30pm
Click here to Register
View all archived NATAP webinars here
Current HIV Articles and News Updates
HIV
CROI:
Time to Viremia and Frequency of Post-Treatment Control Among 382 "Placebo-Treated" ATI Participants
- (03/22/25)
 
CROI:
Effect of ART Start Time, ART Duration, and Elite Control on HIV Transcription
- (03/22/25)
 
CROI:
Obesity and Metabolic Comorbidities in Young Adults With Perinatal HIV Exposure Without Infection
- (03/22/25)
 
CROI:
Achievement of Virologic Suppression in the PROMISE-US Study (Ibalizumab) in Subjects Viremic at Baseline
- (03/21/25)
 
CROI:
Sexual Behaviors Among Gay, Bisexual, and Men who Have Sex with Men (GBMSM) Infected with MPXV in California
- (03/21/25)
 
CROI:
Long-Acting Cabotegravir and Rilpivirine in Older People with HIV in the GEPPO Cohort
- (03/21/25)
 
CROI:
Tecovirimat Is Safe but Not Efficacious in People With Clade II Mpox
- (03/21/25)
 
CROI:
Host and Disease Factors Were Not Associated With Mpox Resolution in Participants Receiving Tpoxx
- (03/21/25)
 
CROI:
DOLPHIN Moms: Pharmacokinetics and HIV suppression with dolutegravir and 1HP or 3HP in pregnancy
- (03/21/25)
 
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
 
Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta
- (12/18/24)
 
More Hep D Articles...
 
Aging & Perinatally Acquired HIV
 
CROI:
Impact of HIV Infection on Adipose Tissue Fibrosis and Its Association With Insulin Resistance
- (03/22/25)
 
CROI:
Incidence and Risk Factors for Neurocognitive Disorders Among Persons with HIV in Washington, DC
- (03/22/25)
 
CROI:
Epigenetic biomarkers of biological age as predictors of AIDS, non-AIDS events and diseases characteristics of aging in persons with HIV
- (03/22/25)
 
CROI:
Long-term Outcomes of Young Adults with Perinatal HIV Infection in the U.S.
- (03/22/25)
 
CROI:
Frailty Is Associated With Higher MACE Incidence but Does Not Appear to Modify Pitavastatin Effects
- (03/22/25)
 
CROI:
Semaglutide Stabilizes Epigenetic Aging in People With HIV-Associated Lipohypertrophy
- (03/22/25)
 
CROI:
HIV and Antiretrovirals have unique in vivo effects on insulin resistance in HIV
- (03/22/25)
 
CROI:
Highly durable seroprotection with HepB-CpG vaccine in people with HIV (PWH): ACTG A5379 (BEeHIVe)
- (03/22/25)
 
CROI:
Menopause is Associated with Faster Increases in Insulin Resistance in Women with HIV
- (03/22/25)
 
CROI:
Obstructive Sleep Apnea and Prevalent Diabetes Mellitus in the Multicenter AIDS Cohort Study
- (03/22/25)
 
More Aging & HIV Articles...
 
PrEP
 
CROI:
Home CAB/RPV Provides Novel Approach to Achieve Viral Suppression in PWH With Adherence Challenges
- (03/17/25)
 
CROI:
Estimation of Prevention-Effective CAB-LA Concentrations Among MSM/TGW in HPTN 083
- (03/17/25)
 
CROI:
PILLAR Month 12 Clinical Results: Zero HIV Acquisition and High Persistence With CAB LA for PrEP
- (03/17/25)
 
CROI:
Performance of HIV RNA Screening in the Context of Long-Acting Injectable Cabotegravir in HPTN 084
- (03/17/25)
 
CROI:
Diagnosis, Resistance, and ART Outcomes after HIV Acquisition on CAB-LA PrEP in Routine Care in U.S.
- (03/17/25)
 
CROI:
RESPONSE TO HIV TREATMENT AFTER LONG-ACTING CABOTEGRAVIR PRE-EXPOSURE PROPHYLAXIS IN HPTN 083
- (03/17/25)
 
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
CROI:
Preclinical Pharmacokinetic Assessment of a Long-acting Solid Injectable for Hepatitis C Virus
- (03/22/25)
 
CROI:
Direct Acting Antiviral Initiation among People with HIV and HCV in North America: Factors Driving the Treatment Gap
- (03/22/25)
 
CROI:
Comorbidities among Medicaid Enrollees with Chronic Hepatitis C, 2016-2020
- (03/20/25)
 
CROI:
Trends in incident HCV infection among PWH engaged in care in the US-1995-2023: 2-fold increase in MSM; high stable rates among PWID & MSM-WID
- (03/17/25)
 
CROI:
Safety and Efficacy of Glecaprevir/Pibrentasvir for 8 Weeks for Treatment of Acute Hepatitis C Virus Infection in People Living with HIV
- (03/11/25)
 
CROI:
Impact of HIV Infection on the Dynamics of Liver Stiffness After HCV Cure
- (03/11/25)
 
Estimating hepatitis C prevalence in the United States, 2017-2020
- (12/29/25)
 
Racial and Ethnic Disparities in Hepatitis C Care in Reproductive-Aged Women With Opioid Use Disorder: 10% HCV treatment rates; African-Americans 25% less likely to be screened
- (12/28/24)
 
CDC and SAMHSA Leaders Encourage HIV and Viral Hepatitis Testing in Substance Use Disorder Treatment
- (12/28/24)
 
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
 
CROI:
Highly durable seroprotection with HepB-CpG vaccine in people with HIV (PWH): ACTG A5379 (BEeHIVe)
- (03/22/25)
 
CROI:
HBsAg SEROCLEARANCE IN HIV AND HBV-COINFECTED PATIENTS IN THE ERA OF TENOFOVIR-CONTAINING THERAPY
- (03/20/25)
 
CROI:
Hepatitis B Reactivation in PWH With Isolated Anti-Core Pattern on Therapies Excluding Tenofovir
- (03/20/25)
 
CROI:
HBV Reactivation Post-switch to HBV-inactive ART: A Scoping Review
- (03/20/25)
 
More Hep B Articles...
 
Fatty Liver, NAFLD, NASH
 
CROI:
Lipidomics of metabolic dysfunction-associated steatotic liver disease post-HCV eradication in PWH
- (03/20/25)
 
CROI:
Liver Steatosis progression with Integrase Inhibitors in HIV Adults in Low-/Middle-Income Countries
- (03/20/25)
 
CROI:
Semaglutide Improves Steatohepatitis in People With HIV: The SLIM LIVER Study
- (03/20/25)
 
CROI:
Evaluation of different non-invasive models in assessing lean MAFLD among PLWH: High rates of Lean MAFLD
- (03/20/25)
 
CROI:
Effects of Semaglutide on Gut Microbiota in People With HIV: The SLIM LIVER Study
- (03/20/25)
 
CROI:
Determinants of Steatotic Liver Disease Among People with HIV in Europe and Australia
- (03/20/25)
 
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
https://academicmedicaleducation.com/meeting/2nd-african-workshop-women-hiv-2025
https://academicmedicaleducation.com/meeting/2nd-menopause-hiv-webinar-2025
https://www.croiconference.org
https://academicmedicaleducation.com/meeting/15th-international-workshop-women-hiv-2025
https://acthiv.org/
https://ddw.org/
https://www.easlcongress.eu/
https://asm.org/Events/ASM-Microbe/Home
IAS 2025, the 13th IAS Conference on HIV Science,
Kigali, Rwanda, July 13 to 17,
pre-conferences on 13 July.
https://www.iasociety.org/conferences/ias2025
https://academicmedicaleducation.com/meeting/26th-international-workshop-clinical-pharmacology-hiv-hepatitis-and-other-antiviral-drugs
https://academicmedicaleducation.com/meeting/11th-international-viral-hepatitis-elimination-meeting-ivhem-2025
https://academicmedicaleducation.com/meeting/8th-conference-liver-disease-africa-colda-2025
https://www.eacsociety.org/european-aids-conference/european-aids-conference/
https://idweek.org/
https://academicmedicaleducation.com/meeting/16th-international-workshop-hiv-aging-2025
https://www.aasld.org/the-liver-meeting
https://neurohiv.com/